Skip to content

Influence of Closed Suction Drainage After Total Knee Replacement.

Influence of Closed Suction Drainage After Total Knee Replacement on Patient's Reported Outcome and Basic Morphology Results, and Inflammation Factors

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03995160
Acronym
TKR
Enrollment
100
Registered
2019-06-21
Start date
2022-03-01
Completion date
2023-03-01
Last updated
2021-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Knee Replacement

Keywords

total, knee, arthroplasty, tkr, drainage, haematoma

Brief summary

The aim of the study will be to compare functional outcomes, basic morphology results, number of blood transfusions, costs of hospitalization, and inflammation factors, following total knee replacement (with use of one type of endoprosthesis) comparing use of closed suction drainage (CSD). Use of closed suction drainage may have influence on patients functional outcome.

Detailed description

Patients with primary knee osteoarthritis will be included in a randomized controlled trial and assigned to total knee arthroplasty with or without closed suction drainage. Subjects will be evaluated preoperatively, 1-day, 3-, 6- and 12-month postoperatively. Change in morphology results will be measured by comparing preoperative and postoperative levels of haematocrite, haemoglobin, erythrocytes, and platelets. Change in the number of blood transfusions will be measured by analyzing the number of needed transfusion of packed red blood cells in the postoperative period during stay in the hospital. Change in levels of inflammation factors will be measured by analyzing the level of C-reactive protein in first and third day postoperatively. Change in body temperature wille be measured daily by analyzing body temperature from day of the surgery until the day of discharge from the hospital Presence of haematoma will be evaluated daily in the postoperative period by clinical examination. Change in Western Ontario and McMasters University Osteoarthritis Index (WOMAC) Pain Score will be measured from baseline (can be measured anytime to a maximum of one month before surgery) 3,6 and 12 months post-operatively Change in Western Ontario and McMasters University Osteoarthritis Index (WOMAC) Function Score will be measured from baseline (can be measured anytime to a maximum of one month before surgery) 3,6 and 12 months post-operatively Costs of hospitalization will be measured by comparing cost of hospitalization between two analyzed groups

Interventions

PROCEDUREUse of closed suction drainage following total knee arthroplasty

Use of closed suction drainage following total knee arthroplasty

PROCEDUREAbstain of using a closed suction drainage

Abstain of using a closed suction drainage following total knee arthroplasty

Sponsors

Centre of Postgraduate Medical Education
CollaboratorOTHER
Medical University of Warsaw
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* patient's consent for anticipation in the study * arthroplasty in one knee

Exclusion criteria

* patient's lack of consent for anticipation in the study * haematological diseases * reoperations in the area of endoprosthesis * medical history of any surgical intervention on the lower limb

Design outcomes

Primary

MeasureTime frameDescription
Change in platelets levelsfrom baseline (can be measured anytime to a maximum of one month before surgery) to 1-day, 3,6 and 12 months post-operativelyMeasuring results of platelets (number/ml)
Change in the number of blood transfusionsfrom baseline to the 1-,2-,3- days postoperativelyMeasuring the number of needed transfusion of packed red blood cells in the postoperative period
Change in levels of inflammation factorsfrom baseline (can be measured anytime to a maximum of one month before surgery) to 1-day, 3,6 and 12 months post-operativelyMeasuring the level of C-reactive protein
Change in haemoglobin levelsfrom baseline (can be measured anytime to a maximum of one month before surgery) to 1-day, 3,6 and 12 months post-operativelyMeasuring results of haemoglobin (g/dL)
Change in erythrocytes levelsfrom baseline (can be measured anytime to a maximum of one month before surgery) to 1-day, 3,6 and 12 months post-operativelyMeasuring results of erythrocytes (number/ml)
Change in haematocrite levelsfrom baseline (can be measured anytime to a maximum of one month before surgery) to 1-day, 3,6 and 12 months post-operativelyMeasuring results of haematocrite (in percentage in 1 ml of blood sample)

Secondary

MeasureTime frameDescription
Change in Western Ontario and McMasters University Osteoarthritis Index (WOMAC) Function Score from baselinefrom baseline (can be measured anytime to a maximum of one month before surgery) 3,6 and 12 months post-operativelyThe WOMAC Function score is derived from a sub-section of the Knee injury and Osteoarthritis Outcome Score (KOOS) Knee Survey. The WOMAC Function scores range from 0-100 with lower scores considered to have better function.
Change in body temperaturefrom baseline to the 1-,2-,3- days postoperativelyMeasuring body temperature from day of the surgery to the hospital until the day of discharge from the hospital
Influence of using CSD on costs of hospitalizationfrom baseline to the one year postoperativelyComparing cost of hospitalization between two analyzed groups
Change in Western Ontario and McMasters University Osteoarthritis Index (WOMAC) Pain Score from baselinefrom baseline (can be measured anytime to a maximum of one month before surgery) 3,6 and 12 months post-operativelyThe WOMAC Pain score is derived from a sub-section of the Knee injury and Osteoarthritis Outcome Score (KOOS) Knee Survey. The WOMAC Pain scores range from 0-100 with lower scores considered lower pain.

Contacts

Primary ContactBartosz Maciąg
bartosz.maciag94@gmail.com+48 881568144
Backup ContactMarcin Wojewodzki
dlamarcinawoj@gmail.com+48 60446187

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026